Page last updated: 2024-11-02

phenylbutazone and Zollinger-Ellison Syndrome

phenylbutazone has been researched along with Zollinger-Ellison Syndrome in 2 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Zollinger-Ellison Syndrome: A syndrome that is characterized by the triad of severe PEPTIC ULCER, hypersecretion of GASTRIC ACID, and GASTRIN-producing tumors of the PANCREAS or other tissue (GASTRINOMA). This syndrome may be sporadic or be associated with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FINKBINER, RB1
RICHARDSON, FM1
Neumayr, A1

Other Studies

2 other studies available for phenylbutazone and Zollinger-Ellison Syndrome

ArticleYear
THE RESISTANT ULCER.
    Medical science, 1963, Volume: 14

    Topics: Alcoholic Beverages; Antacids; Diet; Diet Therapy; Gastrectomy; Glycopyrrolate; Humans; Parasympatho

1963
[Peptic ulcer].
    Leber, Magen, Darm, 1972, Volume: 2, Issue:4

    Topics: Animals; Aspirin; Dogs; Endocrine System Diseases; Gastric Juice; Humans; Hyperparathyroidism; Iatro

1972